Format

Send to

Choose Destination
Int J Gynaecol Obstet. 2018 May;141(2):245-249. doi: 10.1002/ijgo.12419. Epub 2018 Jan 3.

Trends in serum human chorionic gonadotropin levels 0-4 days after methotrexate administration for predicting tubal ectopic pregnancy treatment success.

Author information

1
Department of Obstetrics and Gynecology, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, New Territories, Hong Kong.

Abstract

OBJECTIVE:

To evaluate serum human chorionic gonadotropin (HCG) levels 0-4 days after single-dose methotrexate administration for tubal ectopic pregnancy.

METHODS:

The present retrospective study included women with tubal ectopic pregnancy treated by methotrexate at a tertiary hospital in Hong Kong, China, between January 1, 2007, and December 31, 2016. Patients were stratified serum HCG levels rose or fell from day 0-4 post-administration. Trends in day 0-4 serum HCG to predict treatment success were compared with that of day 4-7 serum HCG. The optimal drop in HCG was identified by receiver operating characteristic curve analysis.

RESULTS:

There were 102 patients included. The positive predictive value (PPV) of day 0-4 serum HCG for treatment success was 91% (95% confidence interval [CI] 82-96), which is comparable to the current criterion of a 15% drop in day 4-7 serum HCG (PPV 91%, 95% CI 84-95). A 6% drop in day 0-4 serum HCG was the best predictor of treatment success (PPV 96%, 95% CI 86-99).

CONCLUSION:

A drop in day 0-4 serum HCG provided earlier prognostic information and was not inferior to the current criterion.

KEYWORDS:

Human chorionic gonadotrophin; Methotrexate; Tubal ectopic pregnancy

PMID:
29214643
DOI:
10.1002/ijgo.12419
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center